ADMA Biologics Inc. (ADMA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ADMA Biologics Inc.

    NASDAQ: ADMA · Real-Time Price · USD
    14.15
    -0.51 (-3.48%)
    At close: Oct 06, 2025, 1:11 PM

    ADMA Biologics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 197.67M -28.24M -65.9M -71.65M
    Depreciation & Amortization
    		 8.04M 8.33M 7.11M 5.5M
    Stock-Based Compensation
    		 13.62M 6.19M 5.21M 3.49M
    Other Working Capital
    		 -2.78M 7.58M 6.4M 5.49M
    Other Non-Cash Items
    		 -78.92M 32.64M 12.35M 1.75M
    Deferred Income Tax
    		 n/a n/a n/a 220.76K
    Change in Working Capital
    		 -18.54M -10.12M -18.29M -51.68M
    Operating Cash Flow
    		 118.67M 8.8M -59.51M -112.37M
    Capital Expenditures
    		 -8.57M -4.98M -13.91M -13.51M
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 -349K -210K n/a n/a
    Investing Cash Flow
    		 -8.57M -4.98M -13.91M -13.51M
    Debt Repayment
    		 -60M -23.6M 51.71M -34K
    Common Stock Repurchased
    		 n/a -1.42M n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 1.7M -13.97M -7.51M -62K
    Financial Cash Flow
    		 -58.3M -38.99M 108.85M 121.05M
    Net Cash Flow
    		 51.8M -35.17M 35.43M -4.83M
    Free Cash Flow
    		 110.1M 3.82M -73.42M -125.88M

    Add to Watchlist